Population immunity to clade 2.3.4.4b H5N1 is dominated by anti-neuraminidase antibodies.

Saved in:
Bibliographic Details
Title: Population immunity to clade 2.3.4.4b H5N1 is dominated by anti-neuraminidase antibodies.
Authors: Singh G; Department of Microbiology, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA., Bhavsar D; Department of Microbiology, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA., Hermann E; Ignaz Semmelweis Institute, Interuniversity Institute for Infection Research, Medical University of Vienna, Vienna, Austria., Gleason C; Department of Microbiology, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA., Singh Sandhu H; Department of Microbiology, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA., Singh P; Department of Microbiology, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA., Nardulli JR; Department of Microbiology, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA., Lyttle N; Department of Microbiology, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA., Chen Y; Department of Microbiology, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA., Sabaiduc S; Immunization Programs and Vaccine Preventable Diseases Service, BC Centre for Disease Control, Vancouver, British Columbia, Canada., Peña Alzua G; Department of Microbiology, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA., Skowronski DM; Immunization Programs and Vaccine Preventable Diseases Service, BC Centre for Disease Control, Vancouver, British Columbia, Canada.; School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada., Simon V; Department of Microbiology, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.; The Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA., Krammer F; Department of Microbiology, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.; Ignaz Semmelweis Institute, Interuniversity Institute for Infection Research, Medical University of Vienna, Vienna, Austria.; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.; Ludwig Boltzmann Institute for Science Outreach and Pandemic Preparedness at the Medical University of Vienna, Vienna, Austria.
Source: MBio [mBio] 2026 May 13; Vol. 17 (5), pp. e0044526. Date of Electronic Publication: 2026 Apr 13.
Publication Type: Journal Article
Journal Info: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 101519231 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2150-7511 (Electronic) NLM ISO Abbreviation: mBio Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2150-7511
DOI:10.1128/mbio.00445-26